会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Lock mechanism for automobile rear seat
    • 汽车后座锁定机构
    • US08939511B2
    • 2015-01-27
    • US13576350
    • 2011-02-15
    • Sanji MajimaKen KuroiwaAkira OgisoKiyohiko KamataHiroyuki Nozaki
    • Sanji MajimaKen KuroiwaAkira OgisoKiyohiko KamataHiroyuki Nozaki
    • B60N2/20B60N2/36B60N2/22
    • B60N2/366B60N2/2245
    • A first and a second surface of a latch for a seat permit sliding passage of the latch relative to a front leg of a striker, upon contact of the front leg with either of the first and second surfaces. A third surface in a containing space of the latch stops the latch by contacting the front leg. The third surface is arranged such that a rear leg of the striker is brought in alignment with a lock groove of the latch upon contact of the front leg with the third surface. The latch can be guided along the second surface when the second surface contacts the front leg, so that the second surface slides on and past the front leg. By continuously unfolding the seat back upwards until the third surface contacts the front leg, the seat back can be set to a design reference position.
    • 当前腿与第一和第二表面中的任一个接触时,用于座位的闩锁的第一和第二表面允许闩锁相对于撞针的前腿滑动通道。 闩锁的容纳空间中的第三表面通过接触前腿而停止闩锁。 第三表面布置成使得当前腿与第三表面接触时,撞针的后腿与闩锁的锁定槽对准。 当第二表面接触前腿时,可以沿着第二表面引导闩锁,使得第二表面在前腿上滑动并经过前腿。 通过将座椅向上延伸展开直到第三表面接触前腿,座椅靠背可被设定为设计参考位置。
    • 17. 发明授权
    • Mevalonolactone derivatives
    • 甲酰戊内酯衍生物
    • US4198425A
    • 1980-04-15
    • US903575
    • 1978-05-08
    • Seiji MitsuiAkira OgisoAkira Indo
    • Seiji MitsuiAkira OgisoAkira Indo
    • A61K31/365A61K31/366A61P3/06A61P9/10C07C45/72C07C49/223C07C49/255C07D309/30
    • C07D309/30C07C45/72
    • This invention concerns novel mevalonolactone derivatives having the formula ##STR1## wherein A represents a direct linkage, methylene, ethylene, trimethylene or vinylene group; R.sup.1 represents hydrogen atom, or an aliphatic acyl group, benzoyl group, or a benzoyl group substituted with hydroxy, lower alkoxy, aliphatic acyloxy or halogen; R.sup.2 represents hydrogen atom, a halogen atom or methyl group; and R.sup.3, R.sup.4 and R.sup.5 are same or different and each represents hydrogen atom, a halogen atom, a lower alkyl group with or without halogen as the substituent, phenyl group, or a phenyl group substituted with halogen, lower alkoxy, aliphatic acyloxy or lower alkyl with or without halogen, or a group represented by the formula R.sup.6 O-- (in the formula, R.sup.6 means hydrogen atom, an aliphatic acyl group, benzoyl group, phenyl group, a phenylalkyl group, cinnamyl group, or a group of benzoyl, phenyl, phenylalkyl or cinnamyl in all of which the aromatic ring is substituted with hydroxy, halogen, lower alkoxy, aliphatic acyloxy or lower alkyl with or without halogen as the substituent, or a lower alkyl group with or without halogen as the substituent).The compounds are useful for the treatment of hyperlipidemia.They may be prepared by halo-lactonizing the corresponding .gamma.,.delta.-unsaturated carboxylic acid derivatives and optionally dehalogenating the resulting product, or lactonizing the corresponding .delta.-hydroxy-carboxylic acid derivatives.
    • 本发明涉及具有下式的新型甲羟戊酸内酯衍生物:其中A代表直链,亚甲基,亚乙基,三亚甲基或亚乙烯基; R1表示氢原子,或脂族酰基,苯甲酰基或被羟基,低级烷氧基,脂族酰氧基或卤素取代的苯甲酰基; R2表示氢原子,卤素原子或甲基; 并且R 3,R 4和R 5相同或不同,各自表示氢原子,卤原子,具有或不具有卤素作为取代基的低级烷基,苯基或被卤素,低级烷氧基,脂族酰氧基或低级 具有或不具有卤素的烷基或由式R6O-表示的基团(在式中,R6表示氢原子,脂族酰基,苯甲酰基,苯基,苯基烷基,肉桂基或苯甲酰基,苯基 ,其中所有芳基被羟基,卤素,低级烷氧基,脂族酰氧基或具有或不具有卤素作为取代基的低级烷基或具有或不具有卤素作为取代基的低级烷基取代的苯基烷基或肉桂基)。 该化合物可用于治疗高脂血症。 它们可以通过卤代 - 内酯化相应的γ,β-不饱和羧酸衍生物和任选地使得到的产物脱卤,或内酯化相应的δ-羟基 - 羧酸衍生物来制备。